Ivosidenib (IVO; AG-120) in IDH1-Mutant Newly-Diagnosed Acute Myeloid Leukemia (ND AML): Updated Results from a Phase 1 Study

Subjects

Subjects :

Cancer Research
IDH1
Oncology
business.industry
Mutant
Cancer research
Myeloid leukemia
Medicine
Hematology
Newly diagnosed
business

Details

ISSN :

21522650

Volume :

19

Database :

OpenAIRE

Journal :

Clinical Lymphoma Myeloma and Leukemia

Accession number :

edsair.doi...........23c6a63f63e72d7873df2a3653b6589c

Full Text :

https://doi.org/10.1016/j.clml.2019.07.094